What’s the difference between CRP and High Sensitivity CRP?
C-reactive protein (CRP) is a biomarker used to measure the levels of inflammation in the body. It is produced by the liver in response to inflammation and can be used to diagnose and monitor various conditions, such as infections, autoimmune diseases, and cardiovascular diseases. However, there is a difference between CRP and high-sensitivity CRP (hs-CRP) in terms of their sensitivity and specific applications.
CRP is a general marker that indicates the presence of inflammation, but it is not sensitive enough to detect low levels of inflammation. On the other hand, hs-CRP is a more sensitive version of CRP that can detect even minimal amounts of inflammation. This makes hs-CRP a valuable tool for assessing the risk of cardiovascular diseases, as even low levels of chronic inflammation have been linked to an increased risk of heart disease.
The main difference in the use of CRP and hs-CRP lies in their respective applications. CRP is typically used as a diagnostic tool to confirm the presence of inflammation and to monitor the response to treatment. It can also be used to assess the severity of certain conditions, such as infections or autoimmune diseases. On the other hand, hs-CRP is primarily used to assess the risk of cardiovascular diseases in individuals who do not have any symptoms. It is often included in cardiovascular risk assessment panels alongside other factors, such as cholesterol levels and blood pressure.
The Diagnostic Kit for C-Reactive Protein (Fluorescence Immunochromatographic Assay) produced by Wizbiotech has a wide linear range, which can not only achieve the function of CRP detection but also serve as a hypersensitive CRP to assess the risk of cardiovascular disease in patients. Besides the CRP test kit, Xiamen Wiz Biotech Co., Ltd. also provide other inflammation marker test kit, which includes SAA, HBP, PCT, etc.
Xiamen Wiz Biotech Co., Ltd. is a high-tech company engaged in the research and development, production and sales of rapid diagnostic reagents and instruments. Focusing on technological innovation, WIZBIOTECH develops POCT testing reagents and instruments and takes advantage of existing channels to expand the medical market, to become a leader in the field of rapid diagnostic POCT. At present, WIZ has a mature immune chromatography technology platform, and more than 120 reagents have been certified in China and abroad, covering SARS CoV-2 solutions, gastrointestinal function, infection, infectious disease, hepatitis, AIDS, and other series of products. In addition, the company has also made significant progress in the layout of chemiluminescence, microfluidic platforms, molecular diagnostics, and other technology platforms, to build competitive barriers and win international competitiveness.
